Could two old drugs beat long COVID? new trial aims to find out
Disease control
Not yet recruiting
This study tests whether two FDA-approved drugs, maraviroc and atorvastatin, can help people with Long COVID. 252 adults aged 18-65 with persistent symptoms will take either the drug combination or a placebo for 16 weeks. The main goal is to see if it reduces fatigue and improves…
Phase: PHASE2, PHASE3 • Sponsor: HealthBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC